Evaluation of the Hepatitis B Vaccination Programme in Medical Students in a Dutch University Hospital
- PMID: 33498258
- PMCID: PMC7909269
- DOI: 10.3390/vaccines9020069
Evaluation of the Hepatitis B Vaccination Programme in Medical Students in a Dutch University Hospital
Abstract
Healthcare workers (HCW) are at increased risk of contracting hepatitis B virus (HBV) and are, therefore, vaccinated pre-exposure. In this study, the HBV vaccination programme for medical students in a university hospital in the Netherlands was evaluated. In the first part, the effectiveness of the programme, which consisted of a vaccination with Engerix-B® at 0, 1, and 6 months, was retrospectively evaluated over 7 years (2012-2019). In the second part of this study, we followed students (the 2019 cohort) who had previously been vaccinated against HBV vaccination (4-262 months prior to primary presentation) in order to investigate the most efficient strategy to obtain an adequate anti hepatitis B surface antigen titre. In the latter, titre determination was performed directly during primary presentation instead of giving previously vaccinated students a booster vaccination first. The vaccination programme, as evaluated in the retrospective first part of the study, was effective (surpassed the protection limit of 10 IU/L) in 98.8 percent of the students (95% CI (98.4-99.2)). In the second part of our study, we found that 80 percent (95% CI (70-87)) of the students who had previously been vaccinated against HBV were still sufficiently protected and did not require a booster vaccination. With this strategy, the previously vaccinated students needed an average of 1.4 appointments instead of the 2 appointments needed with the former strategy. This knowledge is important and can save time and resources in the process of occupational HBV vaccination of HCW.
Keywords: anti-HBs; healthcare workers; hepatitis B; long-term protection; vaccination.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


References
-
- Ryan K.J., Ray C.G., Sherris J.C. Sherris Medical Microbiology. McGraw-Hill Medical; New York, NY, USA: 2010.
-
- European Centre for Disease Prevention and Control . Monitoring the Responses to Hepatitis B and C Epidemics in EU/EEA Member States, 2019. ECDC; Stockholm, Sweden: 2020.
-
- WHO Hepatitis B. [(accessed on 6 January 2021)]; Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
-
- European Centre for Disease Prevention and Control . Hepatitis B ECDC Annual Epidemiological Report for 2017. ECDC; Stockholm, Sweden: 2019.
LinkOut - more resources
Full Text Sources
Other Literature Sources